The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP

Journal of Molecular Medicine

Volumn 93, Issue 4, 2015, Pages 457-467

  Jimeno, Rebeca ^a   Gomariz, Rosa P ^a   Garín, Marina ^b   Gutiérrez Cañas, Irene ^a   González Álvaro, Isidoro ^c   Carrión, Mar ^a   Galindo, María ^d   Leceta, Javier ^a   Juarranz, Yasmina ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CIEMAT   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d Universidad Complutense   (Spain)

Author keywords

Rheumatoid arthritis; Th1; Th17; Vasoactive intestinal peptide; VPAC receptors

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

CELL CULTURE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; RHEUMATOID ARTHRITIS; TH1 CELL; TH17 CELL;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; TH1 CELLS; TH17 CELLS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84925486573     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-014-1232-4     Document Type: Article

References (35)

1. Dong W, Zhu P (2012) Functional niche of inflamed synovium for Th17-cell expansion and activation in rheumatoid arthritis: implication to clinical therapeutics. Autoimmun Rev 11:844–851
2. Gu C, Wu L, Li X (2013) IL-17 family: cytokines, receptors and signaling. Cytokine 64:477–485
3. Lubberts E, Koenders MI, Oppers-Walgrenn B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van der Berg WB (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659
4. Kim J, Kang S, Kim JK, Kwon G, Koo S (2013) Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann Lab Med 33:52–59
5. Benedetti G, Miossec P (2014) Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur J Immunol 44:339–347
6. Carrión M, Pérez-García S, Jimeno R, Juarranz Y, González-Álvaro I, Pablos JL, Gutiérrez-Cañas I, Gomariz RP (2013) Inflammatory mediators alter IL-17 receptors, IL-12 and IL-23 expression in human osteoarthritic and rheumatoid arthritis sinovial fibroblast. Immunomodulation by VIP. Neuroimmunomodulation 20:274–284
7. Yang XO, Pappu B, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS et al (2008) TH17 lineage differentiation is programmed by orphan nuclear receptors RORα and RORγ. Immunity 28:29–39
8. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F, Napolitani G (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639–646
9. van Hamburg JP, Asmawidjaja PS, Davelaar N, Davelaar N, Mus AM, Colin EM, Hazes JM, Dolhain RJ, Lubberts E (2011) Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblasts interaction, including autocrine interleukin-17A production. Arthritis Rheum 63:73–83
10. Ghoreschi K, Laurence A, Yang XP, Hirahara K, O’Shea JJ (2011) T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol 39:395–401
11. Zúñiga LA, Jain R, Haines C, Cua DJ (2013) Th17 cell development: from the cradle to the grave. Immunol Rev 252:78–88
12. Lexberg MH, Taubner A, Albrecht I, Lepenies I, Richter A, Kamradt T, Radbruch A, Chang HD (2010) IFNγ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol 40:3017–3027
13. + T cells in early rheumatoid arthritis: a marker of anti-CCP seropositivity. PLoS One 7:e42189
14. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Evans JG, Cimaz R, Bajaj-Elliott M, Wedderburn LR (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 107:14751–14756
15. Gomariz RP, Juarranz Y, Abad C, Arranz A, Leceta J, Martinez C (2006) VIP-PACAP system in immunity: new insights for multitarget therapy. Ann N Y Acad Sci 1070:51–74
16. Gutiérrez-Cañas I, Juarranz Y, Santiago B, Martínez C, Gomariz RP, Pablos JL, Leceta J (2008) Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis. Brain Behav Immun 22:312–317
17. Juarranz Y, Gutiérrez-Cañas I, Santiago B, Carrión M, Pablos JL, Gomariz RP (2008) Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Arthritis Rheum 58:1086–1095
18. Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166:4–17
19. Delgado M, Abad C, Martínez C, Leceta J, Gomariz RP (2001) Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7:563–568
20. Leceta J, Gomariz RP, Martínez C, Carrión M, Arranz A, Juarranz Y (2007) Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation. Neuroimmunomodulation 14:134–138
21. Jimeno R, Leceta J, Martínez C, Gutiérrez-Cañas I, Pérez-García S, Carrión M, Gomariz RP, Juarranz Y (2011) Effect of VIP on the balance between cytokines and master regulators of activated helper T cells. Immunol Cell Biol 90:178–186
22. Yadav M, Rosenbaum J, Goetzl EJ (2008) Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile. J Immunol 180:2772–2776
23. Jimeno R, Leceta J, Martínez C, Gutiérrez-Cañas I, Carrión M, Pérez-García S, Garín M, Mellado M, Gomariz RP, Juarranz Y (2014) Vasoactive intestinal peptide maintains the nonpathogenic profile of human Th17-polarized cells. J Mol Neurosci. doi:10.1007/S 12031-014-0318-3
24. Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581
25. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi JI, Kaibara N, Hori A, Iwamoto Y, Yoshikai Y (2008) Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 67:1299–1304
26. Kato H, Endress J, Fox DA (2013) The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts. Mod Rheumatol 23:1140–1150
27. Shen H, Goodall JC, Hill Gaston JS (2009) Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 60:1647–1656
28. Henriques A, Gomes V, Duarte C, Pedreiro S, Carvalheiro T, Areias M, Caseiro A, Gabriel AJ, Laranjeira P, Pais ML et al (2013) Distribution and functional plasticity of peripheral blood Th(c)17 and Th(c)1 in rheumatoid arthritis. Rheumatol Int 33:2093–2099
29. 2 pathway, independent of IL-23. J Immunol 191:1364–1372
30. Martínez C, Ortiz AM, Juarranz Y, Lamana A, Seoane IV, Leceta J, García-Vicuña R, Gomariz RP, González-Álvaro I (2014) Serum levels of vasoactive intestinal peptide as a prognostic marker in early arthritis. PLoS One 9:e85248
31. Yuan FL, Hu W, Lu WG, Li X, Li JP, Xu RS, Li CW, Chen FH, Jin C (2011) Targeting interleukin-21 in rheumatoid arthritis. Mol Biol Rep 38:1717–1721
32. Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L, Senices M, Wu PW, Sibley B, Leathurby Y et al (2007) Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 56:1152–1163
33. Kastirr I, Maglie S, Paroni M et al (2014) IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells. J Immunol. doi:10.4049/jimmunol.1400775
34. Chen G, Hardy K, Buting K, Stephen D, Ma L, Shannon F (2010) Regulation of the IL-21 gene by NFkB transcription factor c-Rel. J Immunol 185:2350–2359
35. Carrión M, Juarranz Y, Seoane IV, Martínez C, González-Álvaro I, Pablos JL, Gutiérrez-Cañas I, Gomariz RP (2014) VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid sinovial fibroblasts to IL-22-mediated joint destruction. J Mol Neurosci 52:10–17